AwardedSpainGoodsDynamic purchasing system€278,138
Adjudicación del Contrato Específico del Medicamento AMIVANTAMAB 350 MG CONCENTRADO PARA SOLUCIÓN, AMIVANTAMAB 1600 MG SOLUCIÓN INYECTABLE Y AMIVANTAMAB 2240 MG SOLUCIÓN INYECTABLE, derivado del Sistema Dinámico de Adquisición del Suministro de Medicamentos Exclusivos, para el Consorci Sanitari de Terrassa
- Published
- Published 5 June 2026
Overview
The Consorci Sanitari de Terrassa has awarded a contract for the supply of Amivantamab in three formulations (350 mg concentrate for solution, 1600 mg injectable solution, and 2240 mg injectable solution) to JANSSEN-CILAG, S.A. for a value of €278,137.80. The contract was awarded on 29 May 2026 through the Dynamic Acquisition System for the supply of exclusive medicines managed by the Consorci de Salut i d'Atenció Social de Catalunya.
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Estimated value
- €278,138
- Procedure
- Selective
- Contract type
- Dynamic purchasing system
- Published
- 5 June 2026
Pharmaceutical productsVarious medicinal products
Award outcome
- Awarded value
- €278,138
- Award date
- 29 May 2026
- Contract period
- 29 May 2026 → 24 May 2027
- JANSSEN-CILAG, S.A.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
5 June 2026
Contracting authority
Consorci Sanitari de Terrassa
Procuring entityTerrassa, Spain
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.